Home/Terremoto Biosciences/Charles Baum, M.D., Ph.D.

CB

Charles Baum, M.D., Ph.D.

Chief Executive Officer

Terremoto Biosciences

Therapeutic Areas

Oncology Genetic Disease

Terremoto Biosciences Pipeline

Drug	Indication	Phase
AKT1 Program	Cancer (Precision Oncology)	Phase 1

Leadership Team at Terremoto Biosciences

James Christensen, Ph.D.

President, Head of Research & Development

View full Terremoto Biosciences profile